Mechanistic work suggested that, paradoxically, obesity results in increased immune aging, tumor progression and PD-1-mediated T cell dysfunction yet increased efficacy of PD-1/PD-L1 blockade in murine models and patients with cancer [35]. This evidence concerns the gene CD274 and obesity due to melanocortin 4 receptor deficiency.